Inherited and acquired corona of coronavirus in the host: Inspiration from the biomolecular corona of nanoparticles
Source abstract
Abstract
The family of coronavirus are named for their crown shape. Encoded by the genetic material inherited from the coronavirus itself, this intrinsic well-known "viral corona" is considered an "inherited corona". After contact with mucosa or the entrance into the host, bare coronaviruses can become covered by a group of dissolved biomolecules to form one or multiple layers of biomolecules. The layers acquired from the surrounding environment are named the "acquired corona". We highlight here the possible role of the acquired corona in the pathogenesis of coronaviruses, which will generate fresh insight into the nature of various coronavirus-host interactions.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: SARS-CoV-2 and COVID-19 Research · SARS-CoV-2 detection and testing · COVID-19 Clinical Research Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (40)
Show source-provided references
1. COVID-19 needs a big science approach10.1126/science.abb8654 ↗
2. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target10.1007/s00134-020-05985-9 ↗
3. On the whereabouts of SARS-CoV-2 in the human body: a systematic review10.1371/journal.ppat.1009037 ↗
4. Medical Treatment Expert Group for10.1056/NEJMoa2002032 ↗
5. Protein-nanoparticle interactions: opportunities and challenges10.1021/cr100440g ↗
6. Complement C4 prevents viral infection through capsid inactivation10.1016/j.chom.2019.02.016 ↗
7. Semen-derived amyloid fibrils drastically enhance HIV infection10.1016/j.cell.2007.10.014 ↗
8. Essential roles for soluble virion-associated heparan sulfonated proteoglycans and growth factors in human papillomavirus infections10.1371/journal.ppat.1002519 ↗
9. Coagulation factor X activates innate immunity to human species C adenovirus10.1126/science.1226625 ↗
10. Time evolution of the nanoparticle protein corona10.1021/nn901372t ↗
11. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts10.1073/pnas.0805135105 ↗
12. Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles10.1021/ja107583h ↗
13. Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles10.1021/nn406018q ↗
14. NanoEHS beyond toxicity – focusing on Biocorona10.1039/C6EN00579A ↗
15. Nanomedicine: evolution of the nanoparticle corona10.1038/nnano.2017.61 ↗
16. A decade of the protein corona10.1021/acsnano.7b08008 ↗
17. Biomolecular coronas provide the biological identity of nanosized materials10.1038/nnano.2012.207 ↗
18. Toxic potential of materials at the nanolevel10.1126/science.1114397 ↗
19. Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles10.1073/pnas.0608582104 ↗
20. Eco-corona vs protein corona: effects of humic substances on corona formation and nanoplastic particle toxicity in Daphnia magna10.1021/acs.est.0c00615 ↗
21. Secreted protein eco-corona mediates uptake and impacts of polystyrene nanoparticles on Daphnia magna10.1016/j.jprot.2015.09.005 ↗
22. Nanocrystal facet modulation to enhance transferrin binding and cellular delivery10.1038/s41467-020-14972-z ↗
23. Biological identity of nanoparticles in vivo: clinical implications of the protein corona10.1016/j.tibtech.2016.08.011 ↗
24. The SARS coronavirus spike glycoprotein is selectively recognized by lung surfactant protein D and activates macrophages10.1016/j.imbio.2006.12.001 ↗
25. The viral protein corona directs viral pathogenesis and amyloid aggregation10.1038/s41467-019-10192-2 ↗
26. Cytokine release syndrome in severe COVID-1910.1126/science.abb8925 ↗
27. β-coronaviruses use lysosomes for egress instead of the biosynthetic secretory pathway10.1016/j.cell.2020.10.039 ↗
28. Pathophysiology, transmission, diagnosis, and treatment of Coronavirus Disease 2019 (COVID-19): a review10.1001/jama.2020.12839 ↗
29. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-1910.1038/s41593-020-00758-5 ↗
30. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms10.1021/acschemneuro.0c00122 ↗
31. SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity10.1038/s41467-020-19808-4 ↗
32. Evidence of foodborne transmission of the coronavirus (COVID-19) through the animal products food supply chain10.1021/acs.est.0c06822 ↗
33. Environmental impacts on the transmission and evolution of COVID-19 combing the knowledge of pathogenic respiratory coronaviruses10.1016/j.envpol.2020.115621 ↗
34. An imperative need for research on the role of environmental factors in transmission of novel coronavirus (COVID-19)10.1021/acs.est.0c01102 ↗
35. Detection of coronavirus in environmental surveillance and risk monitoring for pandemic control10.1039/D0CS00595A ↗
36. The crown and the scepter: roles of the protein corona in nanomedicine10.1002/adma.201805740 ↗
37. Role of protein corona in the biological effect of nanomaterials: Investigating methods10.1016/j.trac.2019.05.039 ↗
38. Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology10.1038/nnano.2013.181 ↗
39. In situ char acterization of protein adsorption onto nanoparticles by fluorescence correlation spectroscopy10.1021/acs.accounts.6b00579 ↗
40. In situ detection of the protein corona in complex environments10.1038/s41467-017-01826-4 ↗